NCT00782041View on ClinicalTrials.gov

Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

August 31, 2003

Conditions
Uterine Neoplasms
Interventions
DRUG

Oxaliplatin

85 mg/m²

DRUG

5-FluoroUracil

2,000 mg/m²

DRUG

Folinic acid

20 mg/m²

Trial Locations (1)

Unknown

Sanofi aventis administrative office, Bangkok

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY